Recovery in Numbers
At The Lotus Collaborative, we believe accountability starts with data. Since 2022, we've administered standardized, clinically validated assessments, including the PHQ-9 for depression, the GAD-7 for anxiety, the EDE-Q for eating disorder symptoms, the PCL-5 for trauma symptoms, and measures of self-compassion and overall wellbeing, to clients at admission and discharge. The results below reflect real outcomes from real clients across more than 1,300 completed assessments.
Depression (PHQ-9)
Clients showed a substantial reduction in depression symptoms over the course of treatment. On average, PHQ-9 scores dropped from 12.9 at admission to 8.1 at discharge, a 37% average reduction. Nearly half of clients (47%) experienced a clinically significant improvement, defined in the research literature as a drop of 5 or more points. Among clients admitted with moderate or mild depression, 46% moved into a lower severity category by the time they were discharged.
Anxiety (GAD-7)
Clients also saw meaningful reductions in anxiety symptoms, with 62% of clients improving between admission and discharge and an average symptom reduction of 26%.
Eating Disorder Symptoms (EDE-Q)
This is where we've seen our strongest outcomes: 84% of clients improved on the EDE-Q between admission and discharge, with an average reduction in symptom severity of 37%. This effect has grown over time. Clients discharged in 2026 showed more than double the average improvement of clients discharged in 2023, reflecting continued refinement of our clinical approach.
Trauma Symptoms (PCL-5)
Many of our clients carry a history of trauma alongside their primary diagnosis. On average, clients' trauma symptom scores moved from a level associated with probable PTSD at admission down to a level below that clinical threshold by discharge. A 33% average reduction.
Self-Compassion and Wellbeing
Recovery isn't only about symptoms decreasing, it's also about what clients gain. Clients reported a 22% average increase in self-compassion and a 22% average increase in overall life satisfaction and wellbeing between admission and discharge.
Our Commitment to Measurement
We publish these numbers because we believe transparency builds trust. Every client who receives care at Lotus is tracked with the same rigor, and we review this data regularly to improve how we treat the people who come to us for help.
"Navigating recovery in a non-recovery focused world feels impossible, but it's not."
- Previous Client
*Data reflects matched clients with both an admission and discharge assessment, collected between January 2022 and July 2026 (2026 figures are year-to-date). Matched pairs: PHQ-9 n=150, GAD-7 n=104, EDE-Q n=106, PCL-5 n=48, Self-Compassion Scale n=147, wellbeing measure n=50. "Improved" reflects any score reduction between admission and discharge; severity/clinical categories follow standard published cutoffs for each measure. Individual results vary; these figures represent aggregate outcomes across our client population and are not a guarantee of any individual client's outcome.
83.8% of clients improved on the EDE-Q (eating disorder symptoms) between admission and discharge (n=106 matched).
37% average reduction in depression severity (PHQ-9), from 12.9 at admission to 8.1 at discharge (n=150 matched) — in line with published in-person IOP benchmarks.
Average trauma symptoms (PCL-5) moved from above to below the clinical PTSD threshold — 39.9 at admission down to 26.5 at discharge, a 33.5% reduction (n=48 matched).
Nearly half of clients (46.7%) had a clinically significant drop in depression — a 5-point-or-greater PHQ-9 reduction, the standard threshold used in the research literature.
62.1% of clients improved on anxiety symptoms (GAD-7) between admission and discharge (n=104 matched).
Self-compassion scores rose 21.6% from admission to discharge (n=147 matched) — a wellbeing gain, not just symptom reduction.
Overall wellbeing/thriving scores (BIT) rose 21.8% from admission to discharge (n=50 matched).
46.3% of clients admitted with moderate or mild depression moved to a lower severity category by discharge (n=67 matched).
Treatment effect has grown year over year: average EDE-Q improvement at discharge nearly doubled, from -3.93 in 2023 to -8.84 in 2026 YTD.
1,300+ completed clinical assessments across 430+ clients since 2022, tracked with validated, published instruments (PHQ-9, GAD-7, EDE-Q, PCL-5, and others) at both admission and discharge.
Recovery in Numbers
Every client completes standardized clinical assessments throughout treatment so we can measure progress.
84%
Improved on our eating disorder measure (EDE-Q) between admission and discharge
37%
average reduction in depression symptom severity (PHQ-9) from admission to discharge
Trauma symptoms
moved, on average, from the clinical PTSD range to below the diagnostic threshold.
At Lotus, we routinely measure progress using nationally recognized clinical assessments. Between 2022 and 2026, we analyzed more than 1,300 assessments across 430+ clients to better understand what supports lasting recovery.
See our full outcomes data →
"Navigating recovery in a non-recovery focused world feels impossible, but it's not."
- Previous Client